Isabel Marzo

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Fluorescent Probe

High Efficiency

Silver Nanoparticles

Multiple Myeloma

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Óscar Gonzalo, Andrea Benedi, Laura Vela, Alberto Anel, Javier Naval, Isabel Marzo
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak. Cells 12 (5) (2023)
Óscar Gonzalo, Andrea Benedi, Laura Vela, Alberto Anel, Javier Naval, Isabel Marzo
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak. Cells 12 (5) (2023)
Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez, Marta Cuenca, Andrea Benedi, Alfonso Serrano Del Valle, Gemma Azaceta, Luis Palomera, Victor Peperzak, Alberto Anel, Javier Naval, Isabel Marzo
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X L in multiple myeloma cell lines partially-dependent on MCL-1 and in plasma cells from patients. Molecular oncology (2023)
Óscar Gonzalo, Andrea Benedi, Laura Vela, Alberto Anel, Javier Naval, Isabel Marzo
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak. Cells 12 (5) (2023)
Chantal Reina-Ortiz, David Giraldos, Gemma Azaceta, Luis Palomera, Isabel Marzo, Javier Naval, Martín Villalba, Alberto Anel
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma. Cells 11 (3) (2022)
Ruth Soler-Agesta, Patricia Guerrero-Ochoa, Joaquín Marco-Brualla, Raquel Ibáñez-Pérez, Isabel Marzo, Luis Martínez-Lostao, Alberto Anel
Conjugation of the 9-kDa Isoform of Granulysin with Liposomes Potentiates Its Cytotoxicity. International journal of molecular sciences 23 (15) (2022)
Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez-Alduán, Gemma Azaceta, Rosana Díez, Beatriz Martínez-Lázaro, Isabel Izquierdo, Luis Palomera, Javier Naval, Alberto Anel, Isabel Marzo
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis. Oncoimmunology 11 (1) (2022)
Patricia Guerrero-Ochoa, Raquel Ibáñez-Pérez, Germán Berbegal-Pinilla, Diederich Aguilar, Isabel Marzo, Francisco Corzana, Martha Minjárez-Sáenz, Javier Macías-León, Blanca Conde, Javier Raso-Pueyo, Ramon Hurtado Guerrero, Alberto Anel
Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment. Biomedicines 10 (6) (2022)
Guillermo Canudo-Barreras, Lourdes Ortego, Anabel Izaga, Isabel Marzo, Raquel P Herrera, María Concepción Gimeno
Synthesis of New Thiourea-Metal Complexes with Promising Anticancer Properties. Molecules (Basel, Switzerland) 26 (22) (2021)
Marta Redrado, Andrea Benedi, Isabel Marzo, María Concepción Gimeno, Vanesa Fernández-Moreira
Dual Emissive Ir(III) Complexes for Photodynamic Therapy and Bioimaging. Pharmaceutics 13 (9) (2021)
Andrés Luengo, Isabel Marzo, Matthew Reback, Isabelle M Daubit, Vanesa Fernández-Moreira, Nils Metzler Nolte, María Concepción Gimeno
Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (53) (2020)
Andrés Luengo, Isabel Marzo, Matthew Reback, Isabelle M Daubit, Vanesa Fernández-Moreira, Nils Metzler Nolte, María Concepción Gimeno
Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (53) (2020)